A phase II, open-label trial of bortezomib (VELCADE®) in combination with gemcitabine and cisplatin in patients with locally advanced or metastatic non-small cell lung cancer

被引：0
|
作者：
E. Kontopodis
A. Kotsakis
N. Kentepozidis
K. Syrigos
N. Ziras
M. Moutsos
G. Filippa
A. Mala
L. Vamvakas
D. Mavroudis
V. Georgoulias
S. Agelaki
机构：
[1] Hellenic Oncology Research Group (HORG),
来源：
Cancer Chemotherapy and Pharmacology | 2016年 / 77卷
关键词：
Bortezomib; Cisplatin; Gemcitabine; Non-small cell lung cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：949 / 956
页数：7
相关论文
共 50 条
  • [1] A phase II, open-label trial of bortezomib (VELCADE®) in combination with gemcitabine and cisplatin in patients with locally advanced or metastatic non-small cell lung cancer
    Kontopodis, E.
    Kotsakis, A.
    Kentepozidis, N.
    Syrigos, K.
    Ziras, N.
    Moutsos, M.
    Filippa, G.
    Mala, A.
    Vamvakas, L.
    Mavroudis, D.
    Georgoulias, V.
    Agelaki, S.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (05) : 949 - 956
  • [2] Randomized phase II evaluation of aprinocarsen in combination with gemcitabine and cisplatin for patients with advanced/metastatic non-small cell lung cancer
    Johan Vansteenkiste
    Jean-Luc Canon
    Henrik Riska
    Robert Pirker
    Patrick Peterson
    William John
    Pekka Mali
    Michael Lahn
    [J]. Investigational New Drugs, 2005, 23 : 263 - 269
  • [3] Phase II trial assessing the combination of gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC)
    Antón, A
    Díaz-Fernández, N
    Larriba, JG
    Vadell, C
    Masutti, B
    Montalar, J
    Barneto, I
    Artal, A
    Rosell, R
    [J]. LUNG CANCER, 1998, 22 (02) : 139 - 148
  • [4] Phase II trial of gemcitabine plus cisplatin in patients with advanced non-small cell lung cancer
    Yun Fan
    Neng-ming Lin
    Sheng-lin Ma
    Lü-hong Luo
    Luo Fang
    Zhi-yu Huang
    Hai-feng Yu
    Feng-qin Wu
    [J]. Acta Pharmacologica Sinica, 2010, 31 : 746 - 752
  • [5] Gemcitabine, vinorelbine and cisplatin combination chemotherapy in advanced non-small cell lung cancer:: a phase II trial
    Laack, E
    Mende, T
    Dürk, H
    Kneba, M
    Dickgreber, N
    Welte, T
    Müller, T
    Scholtze, J
    Graeven, U
    Jasiewicz, Y
    Edler, L
    Hossfeld, DK
    [J]. EUROPEAN JOURNAL OF CANCER, 2002, 38 (05) : 654 - 660
  • [6] Phase II trial of gemcitabine plus cisplatin in patients with advanced non-small cell lung cancer
    Fan, Yun
    Lin, Neng-ming
    Ma, Sheng-lin
    Luo, Lue-hong
    Fang, Luo
    Huang, Zhi-yu
    Yu, Hai-feng
    Wu, Feng-qin
    [J]. ACTA PHARMACOLOGICA SINICA, 2010, 31 (06) : 746 - 752
  • [7] Randomized phase II evaluation of aprinocarsen in combination with gemcitabine and cisplatin for patients with advanced/metastatic non-small cell lung cancer
    Vansteenkiste, J
    Canon, JL
    Riska, H
    Pirker, R
    Peterson, P
    John, W
    Mali, P
    Lahn, M
    [J]. INVESTIGATIONAL NEW DRUGS, 2005, 23 (03) : 263 - 269
  • [8] A phase II trial of the combination of gemcitabine, ifosfamide and cisplatin in the treatment of advanced non-small cell lung cancer
    Vadell-Nadal, C
    Nogué-Aliguer, M
    Fabregat-Mayol, X
    Saigí-Grau, E
    Gallén-Castillo, M
    [J]. LUNG CANCER, 2000, 28 (02) : 109 - 115
  • [9] Interim results of a phase II trial of docetaxel in combination with cisplatin in patients with metastatic or locally advanced non-small cell lung cancer (NSCLC)
    Zalcberg, JR
    Bishop, JF
    Millward, MJ
    Zimet, A
    Laird, J
    Barter, C
    Seward, D
    McKeage, MJ
    Friedlander, ML
    Toner, G
    Berille, J
    Blanc, C
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1084 - 1084
  • [10] Phase II trial of gemcitabine and weekly cisplatin for advanced non-small cell lung cancer
    Shepherd, FA
    Cormier, Y
    Burkes, R
    Evans, WK
    Goss, G
    Klimo, P
    Feld, R
    Taylor, M
    [J]. SEMINARS IN ONCOLOGY, 1997, 24 (03) : 827 - 830
12345